About
Technology
Issues
FAQ
Links
Official Page
Switching to Riociguat from Phosphodiesterase-5 Inhibitors, With or Without Endothelin Receptor Antagonists, in Patients with Pulmonary Arterial Hypertension: Results from the REPLACE Study
site/software ©
exaly
; All materials licenced under
CC by-SA
.